Rare diseases
Investigational molecules
Locations
213 conditions with trials, the busiest first
504 trials across Europe, recruiting first
Study of Metformin Treatment to Maintain Type 2 Diabetes Remission in Patients After Bariatric Surgery
FranceStudy on Aflibercept for Adults with Diabetic Macular Edema or Wet Age-Related Macular Degeneration
CzechiaStudy of Palbociclib with Drug Combinations for Children and Young Adults with Recurrent or Refractory Neuroblastoma and Ewing Sarcoma
CzechiaStudy on the Use of Fludeoxyglucose (18F) in PET/CT Scans for Young Patients with Histiocytosis
PolandStudy on Trametinib Dimethyl Sulfoxide for Children with Refractory Histiocytosis Not Responding to Conventional Treatment
PolandStudy on Vemurafenib for Children with BRAF Mutation-Resistant Histiocytosis
PolandStudy of Cabozantinib in Adults with Advanced Low-Grade Neuroendocrine Tumors
AustriaComparison of dapagliflozin versus metformin treatment in patients with early stage type 2 diabetes to evaluate survival and complications
SwedenStudy on the Effects and Safety of Ladarixin for Adults and Adolescents with Recent Onset Type 1 Diabetes
BelgiumStudy on CK-0045 for Patients with Type 2 Diabetes and Obesity
GermanyStudy on the Safety and Effectiveness of Paltusotine for Patients with Acromegaly
BelgiumStudy of Clenbuterol vs Placebo in Adult Patients with Spinal and Bulbar Muscular Atrophy (SBMA)
ItalyThe therapies tested most often in Endocrine disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
